Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacqueline Maier

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Nature Clinical Practice. Endocrinology & Metabolism|September 26, 2007
Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumorsKnut Krohn, Jacqueline Maier, Ralf Paschke
Vox Sanguinis|February 23, 2026
Hypoxic-hypocapnic red blood cells in PAGGSM additive solution before and after gamma irradiation show improved metabolismSoroth Chey, Jacqueline Maier, Samuel Sowemimo-Coker, et al.
Vox Sanguinis|February 17, 2025
Split red blood cell units contain defined extracellular K<sup>+</sup> levels, which are improved by a washing procedureFabiola Hoppe, Jacqueline Maier, Holger Kirsten, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2005
Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidismMaren Claus, Jacqueline Maier, Ralf Paschke, et al.
The Journal of Molecular Diagnostics : JMD|October 23, 2018
Optimized Digital Droplet PCR for BCR-ABLJacqueline Maier, Thoralf Lange, Michael Cross, et al.
Haematologica|January 10, 2013
JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapseThoralf Lange, Anja Edelmann, Udo Siebolts, et al.
Haematologica|October 16, 2012
The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemiaThoralf Lange, Thomas Ernst, Franz X Gruber, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2019
Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid LeukemiaGeorg-Nikolaus Franke, Jacqueline Maier, Kathrin Wildenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Detection of mutant free circulating tumor DNA in the plasma of patients with gastrointestinal stromal tumor harboring activating mutations of CKIT or PDGFRAJacqueline Maier, Thoralf Lange, Irina Kerle, et al.
Haematologica|July 18, 2009
A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinibThomas Ernst, Franz X Gruber, Oliver Pelz-Ackermann, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Nature Clinical Practice. Endocrinology & Metabolism|September 26, 2007
Mechanisms of disease: hydrogen peroxide, DNA damage and mutagenesis in the development of thyroid tumorsKnut Krohn, Jacqueline Maier, Ralf Paschke
Vox Sanguinis|February 23, 2026
Hypoxic-hypocapnic red blood cells in PAGGSM additive solution before and after gamma irradiation show improved metabolismSoroth Chey, Jacqueline Maier, Samuel Sowemimo-Coker, et al.
Vox Sanguinis|February 17, 2025
Split red blood cell units contain defined extracellular K<sup>+</sup> levels, which are improved by a washing procedureFabiola Hoppe, Jacqueline Maier, Holger Kirsten, et al.
Thyroid : Official Journal of the American Thyroid Association|September 29, 2005
Novel thyrotropin receptor germline mutation (Ile568Val) in a Saxonian family with hereditary nonautoimmune hyperthyroidismMaren Claus, Jacqueline Maier, Ralf Paschke, et al.
The Journal of Molecular Diagnostics : JMD|October 23, 2018
Optimized Digital Droplet PCR for BCR-ABLJacqueline Maier, Thoralf Lange, Michael Cross, et al.
Haematologica|January 10, 2013
JAK2 p.V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapseThoralf Lange, Anja Edelmann, Udo Siebolts, et al.
Haematologica|October 16, 2012
The quantitative level of T315I mutated BCR-ABL predicts for major molecular response to second-line nilotinib or dasatinib treatment in patients with chronic myeloid leukemiaThoralf Lange, Thomas Ernst, Franz X Gruber, et al.
The Journal of Molecular Diagnostics : JMD|November 1, 2019
Comparison of Real-Time Quantitative PCR and Digital Droplet PCR for BCR-ABL1 Monitoring in Patients with Chronic Myeloid LeukemiaGeorg-Nikolaus Franke, Jacqueline Maier, Kathrin Wildenberger, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
Detection of mutant free circulating tumor DNA in the plasma of patients with gastrointestinal stromal tumor harboring activating mutations of CKIT or PDGFRAJacqueline Maier, Thoralf Lange, Irina Kerle, et al.
Haematologica|July 18, 2009
A co-operative evaluation of different methods of detecting BCR-ABL kinase domain mutations in patients with chronic myeloid leukemia on second-line dasatinib or nilotinib therapy after failure of imatinibThomas Ernst, Franz X Gruber, Oliver Pelz-Ackermann, et al.
Pageof 2